Table 2.

Multiple logistic regression analysis of factors possibly associated with prophylactic pancreatic stents use

Factor	p Value
Years of ERCP experience	0.404
Annual personal ERCP volume	0.512
Service Health Authority	0.725
NSAID use	<0.001
Octreotide use	0.079
Antibiotic use	0.856
Intravenous fluid use	0.647
Routine postprocedure amylase measurement	0.948

ERCP, endoscopic retrograde cholangiopancreatography; NSAID, non-steroidal anti-inflammatory drug.